Endometrial Cancer Treatment Market Research Insights 2022-28
Endometrial cancer, often known as uterine cancer, is one of the most prevalent gynecological malignancies, with 2.8 percent of women developing it at some time in their life. Endometrial cancer accounted for 1.8 percent of all malignancies in 2015, as per National Cancer Institute figures, and 3.6 percent of all new cancer cases were identified as endometrial cancer. Endometrial cancer can be detected early, which aids in the selection of appropriate treatment choices. Endometrial malignancies are classified as type I or type II tumors, and the vast majority of individuals identified with endometrial cancer are in the early stages of the disease. As per Yale University School of Medicine in the United States, type I tumors account for 80% of all endometrial cases of cancer identified in the United States in 2014. View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/endometrial-cancer-treatment-market/ Increased knowledge of uterine il